Analysis reveals high accuracy for multicancer classification, indicating therapeutic strategies may benefit from this tool.
These findings demonstrate GraphVar as a robust and interpretable framework for multicancer classification. The model's high accuracy and its ability to identify functionally meaningful genomic signatures indicate its potential as a tool to support precision diagnostics and therapeutic strategies, warranting further translational studies.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: